Mar 07, 2022 / 03:30PM GMT
Max Masucci - Cowen and Company, LLC, Research Division - Senior Analyst
Good morning. Welcome to the 42nd Annual Cowen Healthcare Conference. I'm Max Masucci, one of our three life science and diagnostic tools analyst here at Cowen.
We're excited to have PerkinElmer at the conference again this year. And from Perkin, we have Jamey Mock, CFO. So thanks, Jamey, for spending some time here with us today.
James M. Mock - PerkinElmer, Inc. - Senior VP & CFO
Thanks for having us, Max. Good to see you.
Questions and Answers:
Max Masucci - Cowen and Company, LLC, Research Division - Senior AnalystYes, absolutely. All right. Let's start with a question that is pretty standard across the board for most of our chats. The past fiscal year around 44% of revenues came from America, 31% from Europe, 25% from Asia, 19% of last year's revenues were generated from your diagnostics business in Europe. So just given the dynamics in Ukraine, Eastern Europe, it's worth checking in on your exposure from a customer type